000 01609 a2200469 4500
005 20250517160046.0
264 0 _c20180713
008 201807s 0 0 eng d
022 _a1744-8042
024 7 _a10.2217/pgs-2017-0021
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTong, Hoi Y
245 0 0 _aInfluence of two variants of CYP450 oxidoreductase on the stable dose of acenocoumarol in a Spanish population.
_h[electronic resource]
260 _bPharmacogenomics
_cJun 2017
300 _a797-805 p.
_bdigital
500 _aPublication Type: Journal Article; Observational Study
650 0 4 _aAcenocoumarol
_xadministration & dosage
650 0 4 _aAged
650 0 4 _aAnticoagulants
_xadministration & dosage
650 0 4 _aCross-Sectional Studies
650 0 4 _aCytochrome P-450 Enzyme System
_xgenetics
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFemale
650 0 4 _aGenotype
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPharmacogenetics
_xmethods
650 0 4 _aPolymorphism, Genetic
_xgenetics
650 0 4 _aWhite People
_xgenetics
700 1 _aBorobia, Alberto M
700 1 _aMartínez Ávila, José Carlos
700 1 _aLubomirov, Rubin
700 1 _aMuñoz, Mario
700 1 _aBlanco Bañares, María J
700 1 _aHernández, Rafael
700 1 _aFernández Capitán, Carmen
700 1 _aRamírez, Elena
700 1 _aFrías, Jesús
700 1 _aCarcas, Antonio J
773 0 _tPharmacogenomics
_gvol. 18
_gno. 8
_gp. 797-805
856 4 0 _uhttps://doi.org/10.2217/pgs-2017-0021
_zAvailable from publisher's website
999 _c27256198
_d27256198